DCGN

(redirected from Decode Genetics)
Also found in: Wikipedia.
AcronymDefinition
DCGNDecode Genetics (Iceland)
DCGNDanish Corporate Governance Network
DCGNDevelopment Control Guidance Notes (UK)
DCGNDesign Center for Global Needs (San Francisco State University; California)
DCGNDeutsches Corporate Governance Netzwerk (German: German Corporate Governance Network)
DCGNDazed and Confused Gaming Network (website)
References in periodicals archive ?
Researchers from Iceland's deCode Genetics headed the project, which involved 292,000 participants of European origin, of which approx.
Previously, Dr Ramiya has worked at deCODE Genetics and Abbott Laboratories overseeing the development and manufacturing processes of therapeutics from pre-clinical to Phase III as well as a research associate in the Department of Chemistry at the University of Chicago.
Kari Stefanson, chief executive of deCODE Genetics, a company with data on genes and diseases for the entire population of Iceland.
has agreed to pay $415 million to acquire Decode Genetics.
11 December 2012 a[euro]" US biotechnology company Amgen Inc (NASDAQ:AMGN) has signed a definitive agreement for the acquisition of Icelandic human genetics specialist deCODE Genetics Inc.
Kari Stefansson, chief executive officer of deCODE Genetics in Reykjavik, and his colleagues focused on variants of the amyloid precursor protein (APP) gene.
For instance, in August 2012, Nature published findings by deCODE Genetics of Iceland that provides insight into the genetic underpinnings of autism and schizophrenia, resulting from a genetic mutation linked to the age of the father.
But the new study by DECODE Genetics, an Icelandic company and published in the Nature journal, has shown that most genetic mutations that arise in children are passed down by the father's sperm rather than the mother's eggs.
deCODE genetics, and 23andMe, and, on July 19, the agency warned 15 more companies.
Iceland's Decode Genetics Ehf returned as a private biotech company with new finance Thursday after being acquired from its former parent by a consortium of investors.
deCODE Genetics (Reykjavik, Iceland) has patented nucleic acids comprising the neuregulin 1 gene (NRG1) and encoding NRG1 polypeptides.
Its other findings merely confirm data reported in the June Nature Genetics, contends Kari Stefansson of deCODE Genetics in Reykjavik, Iceland.